Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Bioxcel Therapeutics Inc

Clinical trials sponsored by Bioxcel Therapeutics Inc, explained in plain language.

BioXcel Therapeutics Inc BTAI NASDAQ

Biopharmaceutical company developing therapies for neuropsychiatric and neurological disorders using artificial intelligence.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 2 Completed 10 Terminated 1

Could a dissolving film calm agitated teens? new trial begins

Symptom relief Recruiting now

This early-stage trial tests BXCL501, a dissolving film placed under the tongue, to quickly reduce agitation in children and teens aged 10-17 with schizophrenia or bipolar disorder. About 140 participants will receive either the drug or a placebo. The study measures changes in ag…

Phase: PHASE1 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief

Last updated Aug 13, 2026 00:00 UTC